Advancing Community Oncology in an Era of Uncertainty With Matthew Hadfield, DO, and Jason Hammonds

Read the full interview on Oncology Data Advisor:
https://oncdata.com/advancing-community-oncology-hadfield-hammonds

As cancer care becomes more complex, most patients are still treated close to home in community practices that are under growing economic and regulatory pressure. In this interview, Oncology Data Advisor Editor in Chief Matthew Hadfield, DO, talks with Jason Hammonds, President of Oncology and Multispecialty at McKesson, about how to preserve access to state-of-the-art care outside academic centers.

They discuss the paradox of progress in oncology—rapid advances in targeted therapies, next-generation sequencing (NGS), and clinical trials alongside mounting administrative burden and reimbursement uncertainty. Mr. Hammonds outlines how McKesson is working to make precision oncology and trial enrollment feasible in busy community settings by integrating molecular testing, clinical decision support, and trial-matching tools directly into practice workflows, while also advocating for policies that sustain community oncology.

Hashtags
#CommunityOncology #PrecisionOncology #NGSTesting #ClinicalTrials #OncologyPolicy #CancerCareCloseToHome #HealthEquity #OncologyPractice #OncologyLeadership #OncologyDataAdvisor

Видео Advancing Community Oncology in an Era of Uncertainty With Matthew Hadfield, DO, and Jason Hammonds канала Oncology Data Advisor